SPC
KIDS icon

Sigma Planning Corp’s OrthoPediatrics KIDS Stock Holding History

Sigma Planning Corp’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,320
Closed -$280K – 1022
2019
Q1 		$280K Buy
+6,320
New +$240K 0.02% 708

Other funds holding KIDS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sigma Planning Corp's KIDS Position: Q2 2019 in Review

Sigma Planning Corp sold out of OrthoPediatrics (KIDS) in Q2 2019, closing a stake of 6,320 shares — an estimated $280K sold.

Sigma Planning Corp first reported a position in KIDS in Q1 2019 and held it in 1 quarter. The position peaked at $280K in Q1 2019. 101 funds tracked by Wall St. Rank hold KIDS as of Q2 2019.

  • Sigma Planning Corp reported no remaining OrthoPediatrics position as of Q2 2019 after selling out during the quarter.
  • Sigma Planning Corp sold 6,320 OrthoPediatrics shares in Q2 2019, an estimated $280K.
  • Sigma Planning Corp first reported a position in OrthoPediatrics in Q1 2019 and held it in 1 quarter.
  • Sigma Planning Corp's OrthoPediatrics position peaked at $280K in Q1 2019.
  • 101 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2019.

Based on Sigma Planning Corp's 13F filing for Q2 2019, filed 1 Aug 2019.